Epizyme | Company Profile, Marketing Contacts, Media Spend, Brands

Epizyme is dedicated to rewriting treatment for people with cancer through targeted epigenetic medicines. We aspire to change the standard of care for patients and physicians by developing medicines with fundamentally new mechanisms of action directed at specific causes of hematological malignancies and solid tumors. Our research is yielding exciting new targets for which we are developing novel small molecule programs with the goal of expanding on a pipeline of clinical candidates. Our exceptional team is dedicated to bringing epigenetic therapies to the many patients who need them.